The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance From the American Association for the Study of Liver DiseasesThe Diagnosis and Management

ATAO:TX_1~ADD:ABS:AT/HTC:OS:TX_2~ADD:ABS:AT//ABSH:AT© 2018 Saudi Journal of Gastroenterology | Published by Wolters Kluwer  Medknow 1 Nonalcoholic

Arch Argent Pediatr 2017;115(3):287-293 / 287 Liver disease and dyslipidemia as a manifestation of lysosomal acid lipase deficiency (LAL-D). Clinical and diagnostic aspects,

• THE LIVER WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) • STAGES OF NON-ALCOHOLIC FATTY LIVER DISEASE • NUTRITION BASICS PART 3 PART 4 • FOUR WAYS

Liver diseases I and II hepatitis and liver cirrhosis))[email protected] Done by:Amer Al-Salamat & Laith Sorour • The liver is vulnerable to a wide variety of

Liver Disease in Canada A Crisis in the mAking An Assessment of Liver DiseAse in CAnADA bAseD on AvAiLAbLe DAtA highLights AnD key reCommenDAtions mArCh 2013 2 Liver diseases

PowerPoint PresentationPalliative Care in Chronic Liver Disease Dr. Moe Yeung MD, BSc, CCFP Palliative Care and Family Medicine Clinical Instructor Disclosures • None

The rising prevalence of chronic liver disease is contributing to higher rates of cirrhosis, liver failure and liver cancer. GPs can share the increasing burden with specialist

Gaucher’s disease and liver involvement: A review and our experienceAbstract Background: This article reviews current knowledge of Gaucher’s disease (GD) and

Thomsonin Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)